Companies
Interview with Dr Michael Watts, CEO of Blüm Health: Clinical expertise meets digital innovation
Dr Michael Watts is a UK-based physician and the Co-founder and CEO of Blüm Health Ltd. He has worked with the National Health Service (NHS) since the age of 18 and now plays a pivotal role in bridging clinical practice with technological innovation. In addition to his medical duties, he is a Fellow…
Headline
Dr Michael Watts is a UK-based physician and the Co-founder and CEO of Blüm Health Ltd. He has worked with the National Health Service (NHS) since the age of 18 and now plays a pivotal role in bridging clinical practice with technological innovation. In addition to his medical…
Context
Dr Michael Watts is a UK-based physician and the Co-founder and CEO of Blüm Health Ltd . He has worked with the National Health Service (NHS) since the age of 18 and now plays a pivotal role in bridging clinical practice with technological innovation. In addition to his medical duties, he is a Fellow of the NHS Innovation Accelerator (NIA), a clinical informatician, and a Visiting Professor at Birmingham City University. Recognised as the Young Health Tech Leader of the Year 2024 , Dr Watts has become a key voice in shaping the future of digital healthcare. In this interview with BTW Media, Dr Watts discusses how his clinical background informs his approach to innovation, the importance of regulatory foresight in product development, and how internationalisation can offer both growth and resilience for healthtech startups. Through projects like Verbo, which delivers virtual speech therapy to underserved schoolchildren, he illustrates how digital solutions can drive real-world impact. The following conversation sheds light on his vision, achievements, and the principles guiding Blüm Health’s continued success.
Evidence
Pending intelligence enrichment.
Analysis
Also read: Connected North 2025: Delivering the north’s connected future OUR TAKE : Dr Michael Watts’ journey from NHS physician to digital health innovator exemplifies the powerful fusion of clinical experience and entrepreneurial thinking. His emphasis on compliance, patient-centred design, and proactive international expansion offers a valuable blueprint for early-stage healthtech ventures. Through collaborative efforts like the Verbo project, Blüm Health demonstrates that scalable, affordable, and ethical innovation can genuinely transform care delivery in underserved communities. Watts responded by stressing that being a clinician brings critical advantages, particularly in identifying regulatory risks and patient needs. However, he cautioned that medical knowledge alone is not sufficient. “Innovation should be patient-centred, expert-led, and market-informed,” he said. A notable example came from their burns care app, used by over 20,000 users, which calculates the fluid requirements for burn patients. When asked to integrate photography for clinical use, his team identified the need for digital consent protocols and proactively developed GDPR-compliant consent workflows —demonstrating how clinical foresight can pre-empt legal pitfalls.
Key Points
- Dr Michael Watts, founder of Blüm Health, emphasises the importance of embedding clinical insight into digital health innovation to ensure safety and compliance from the outset.
- The Verbo platform exemplifies how Blüm Health bridges the care gap by delivering virtual speech therapy to underserved schoolchildren.
- Watts advocates for early internationalisation to diversify risk and enrich understanding of culturally sensitive healthcare delivery.
Actions
Pending intelligence enrichment.
